Digital Realization for Business Value | 2023 Digital CMC Summit On-Demand | Presentation
How Digital CMC leaders can build alignment around the purpose, value, and long-term impact of thier strategies
Common barriers for digital initiatives in drug manufacturing, and how to start breaking them down
Where to start building a data-centric culture that will sustain the success of digitalization efforts
How organizations can turn early buy-in successes into sustained investment in holistic transformation
Learn how Digital CMC leaders can break past the pilot.
The urgency is there: drug developers are all feeling the pressure to increase efficiency, accelerate delivery, and maximize quality. The technology is ready too, in today’s growing array of purpose-built digital solutions for drug development. So what’s holding back the industry’s transformation?
That question was top-of-mind for everyone at the 2023 Digital CMC Summit, including Robert Dimitri – Director of Digital Quality Systems at Thermo Fisher Scientific. He and his peers at the IAAE recently published a new white paper on the state of transformation programs in drug manufacturing, and he took the stage to give his expert view on the paper’s conclusions.
In his featured presentation, Robert dives into:
- Cultural and organizational challenges that can cul-de-sac successful pilots and slow adoption of new technologies.
- A digital maturity model that can help leaders plan the journey from foundational frameworks to advanced applications, and gain the alignment they need at each step.
- How digital leaders can translate early wins that secure investment into sustained support for long-term transformation strategies.
Register below to watch the full presentation and take an even closer look at the IAAE’s recommendations.
Watch this session
We’re here to help you deliver